top of page
Report Summary
Market Overview

Global Anticoccidial Drugs Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Anticoccidial Drugs Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, and Other Drug Classes), Drug Action (Coccidiostatic, and Coccidiocidal), Animal ((Livestock Animals (Cattle, Poultry, Other Livestock Animals), and Companion Animals (Dogs, Cats, and Other Companion Animals)), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, and Other Distribution Channels), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Market Overview


The Global Anticoccidial Drugs Market was valued at USD 1,564.9 million in 2023 and is expected to reach USD 2,419.9 million by 2031 while growing at a CAGR of 5.6% during the forecast period (2024-2031).

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global anticoccidial drugs market growth.

Anticoccidial drugs, vital in veterinary medicine, prevent and treat coccidiosis—a parasitic infection by Eimeria protozoa affecting the intestinal tracts of animals like poultry, cattle, and swine. This infection poses economic threats to the livestock industry, causing reduced growth rates, inefficiencies in feed conversion, and higher mortality.


Growing meat consumption and continuous advancements in veterinary medicine are anticipated to boost the anticoccidial drugs market. However, challenges like stringent regulatory approvals and bans on specific drug classes could impede market expansion.


Furthermore, the global anticoccidial drugs industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Drug Class Analysis


The Global Anticoccidial Drugs Market is segmented among Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, and Other Drug Classes, based on Drug Class. In 2023, Antibiotic accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Drug Action Analysis


The Global Anticoccidial Drugs Market is segmented among Coccidiostatic, and Coccidiocidal, based on Drug Action. In 2023, Coccidiostatic accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Anticoccidial Drugs Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Zoetis, Phibro Animal Health Corporation, Huvepharma, Elanco, Biochem Pharma, Ceva, Impextraco NV, Virbac, Boehringer Ingelheim International GmbH, and MSD Animal Health.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Anticoccidial Drugs Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Anticoccidial Drugs Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Anticoccidial Drugs Market Segmentation, By Drug Class

  • Global Anticoccidial Drugs Market Share Analysis, By Drug Class

  • Global Anticoccidial Drugs Market Growth Analysis, By Drug Class

  • Global Anticoccidial Drugs Market Trends, By Drug Class

o Ionophore

o Antibiotic

o Sulphonamides

o Chemical Derivative

o Other Drug Classes

6. Global Anticoccidial Drugs Market Segmentation, By Drug Action

  • Global Anticoccidial Drugs Market Share Analysis, By Drug Action

  • Global Anticoccidial Drugs Market Growth Analysis, By Drug Action

  • Global Anticoccidial Drugs Market Trends, By Drug Action

o Coccidiostatic

o Coccidiocidal

7. Global Anticoccidial Drugs Market Segmentation, By Animal

  • Global Anticoccidial Drugs Market Share Analysis, By Animal

  • Global Anticoccidial Drugs Market Growth Analysis, By Animal

  • Global Anticoccidial Drugs Market Trends, By Animal

o Livestock Animals

Ø Cattle

Ø Poultry

Ø Other Livestock Animals

o Companion Animals

Ø Dogs

Ø Cats

Ø Other Companion Animals

8. Global Anticoccidial Drugs Market Segmentation, By Distribution Channel

  • Global Anticoccidial Drugs Market Share Analysis, By Distribution Channel

  • Global Anticoccidial Drugs Market Growth Analysis, By Distribution Channel

  • Global Anticoccidial Drugs Market Trends, By Distribution Channel

o Veterinary Hospitals

o Retail Pharmacy

o Other Distribution Channels

9. Global Anticoccidial Drugs Market Segmentation, By Region

  • Global Anticoccidial Drugs Market Share Analysis, By Region

  • Global Anticoccidial Drugs Market Growth Analysis, By Region

  • Global Anticoccidial Drugs Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

  • Zoetis *

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Phibro Animal Health Corporation

  • Huvepharma

  • Elanco

  • Biochem Pharma

  • Ceva

  • Impextraco NV

  • Virbac

  • Boehringer Ingelheim International GmbH

  • MSD Animal Health 

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page